Business Description
Galenica Ltd
ISIN : US36337P1021
Share Class Description:
GLLNY: ADRTotal Employee Number:
8,427Compare
Compare
Traded in other countries / regions
GALE.Switzerland0ROG.UKG70.GermanyGALE.Austria1GALE.ItalyGALNF.USA IPO Date
2017-06-30Description
Galenica Ltd is an integrated healthcare service provider in Switzerland. The business is operated from two segments Products & Care and Logistics & IT. The Products & Care segment comprises the Retail business area with offerings for patients and end customers and the Professionals business area with offerings for business customers and partners in the healthcare sector. The Logistics & IT segment comprises the two sectors Wholesale and Logistics & IT Services. These provide services for all those involved in the healthcare sector - pharmacies, drugstores, doctors, hospitals and care homes, partners, and suppliers. Geographically, it operates in Switzerland and Other Countries.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.47 | |||||
Equity-to-Asset | 0.45 | |||||
Debt-to-Equity | 0.17 | |||||
Debt-to-EBITDA | 0.69 | |||||
Interest Coverage | 16.81 | |||||
Piotroski F-Score | 6/9 | |||||
Altman Z-Score | 3.6 | |||||
Beneish M-Score | -2.63 | |||||
WACC vs ROIC | ||||||
Growth Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 4.8 | |||||
3-Year EBITDA Growth Rate | 6.1 | |||||
3-Year EPS without NRI Growth Rate | 5 | |||||
3-Year FCF Growth Rate | 13.4 | |||||
3-Year Book Growth Rate | 6 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate Industry Rank | 5.97 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 4.26 |
Momentum Rank
4/10
| Name | Current | Vs Industry | Vs History |
|---|
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1.15 | |||||
Quick Ratio | 0.73 | |||||
Cash Ratio | 0.12 | |||||
Days Inventory | 45.19 | |||||
Days Sales Outstanding | 45.44 | |||||
Days Payable | 56.93 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Dividend Growth Rate | 3.1 | |||||
Shareholder Yield % | 3.1 |
Profitability Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 27.94 | |||||
Operating Margin % | 5.47 | |||||
Net Margin % | 4.38 | |||||
EBITDA Margin % | 8.51 | |||||
ROE % | 12.14 | |||||
ROA % | 5.76 | |||||
ROIC % | 7.4 | |||||
3-Year ROIIC % | 6.17 | |||||
ROC (Joel Greenblatt) % | 38.83 | |||||
ROCE % | 10.21 | |||||
Years of Profitability over Past 10-Year | 10 | |||||
Moat Score | 4 |
GF Value Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 23.8 | |||||
Forward PE Ratio | 22 | |||||
PE Ratio without NRI | 23.61 | |||||
Shiller PE Ratio | 25.41 | |||||
Price-to-Owner-Earnings | 15.26 | |||||
PEG Ratio | 9.08 | |||||
PS Ratio | 1.04 | |||||
PB Ratio | 2.9 | |||||
Price-to-Tangible-Book | 63.3 | |||||
Price-to-Free-Cash-Flow | 17.67 | |||||
Price-to-Operating-Cash-Flow | 14.38 | |||||
EV-to-EBIT | 18.81 | |||||
EV-to-EBITDA | 12.6 | |||||
EV-to-Revenue | 1.07 | |||||
EV-to-FCF | 18.18 | |||||
Price-to-Projected-FCF | 1.4 | |||||
Price-to-DCF (Earnings Based) | 1.21 | |||||
Price-to-DCF (FCF Based) | 0.84 | |||||
Earnings Yield (Greenblatt) % | 5.32 | |||||
FCF Yield % | 5.67 | |||||
Forward Rate of Return (Yacktman) % | 7.25 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:GLLNY
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Galenica Ltd Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | - | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | - | ||
| 14-Day RSI | - | ||
| 14-Day ATR ($) | - | ||
| 20-Day SMA ($) | - | ||
| 12-1 Month Momentum % | - | ||
| 52-Week Range ($) | 0 - 0 | ||
| Shares Outstanding (Mil) | 199.3 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Galenica Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Galenica Ltd Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Galenica Ltd Frequently Asked Questions
What is Galenica Ltd(GLLNY)'s stock price today?
The current price of GLLNY is $0.00. The 52 week high of GLLNY is $0.00 and 52 week low is $0.00.
When is next earnings date of Galenica Ltd(GLLNY)?
The next earnings date of Galenica Ltd(GLLNY) is .
Does Galenica Ltd(GLLNY) pay dividends? If so, how much?
Galenica Ltd(GLLNY) does not pay dividend.
Guru Commentaries on OTCPK:GLLNY
No articles.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Galenica Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers